# Heartland Express Inc: financial statements, quarterly

HTLD · Nasdaq · CIK 799233 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/htld.md) · [Financials](/companies/htld/financials.md) · [Filings](/companies/htld/filings.md) · [Insiders](/companies/htld/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/htld/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [295](/filings/0000799233-24-000041.md) | [275 d](/filings/0000799233-26-000006.md) | [270](/filings/0000799233-25-000036.md) | [275](/filings/0000799233-25-000044.md) | [260](/filings/0000799233-25-000053.md) | [243 d](/filings/0000799233-26-000006.md) | [219](/filings/0000799233-26-000028.md) | [210](/filings/0000799233-26-000039.md) | [197](/filings/0000799233-25-000053.md) | [179 d](/filings/0000799233-26-000006.md) | [176](/filings/0000799233-26-000028.md) | [184](/filings/0000799233-26-000039.md) |
| Operating income | $m | [(7.4)](/filings/0000799233-24-000041.md) | [10.7 d](/filings/0000799233-26-000006.md) | [(14.4)](/filings/0000799233-25-000036.md) | [0.3](/filings/0000799233-25-000044.md) | [(7.1)](/filings/0000799233-25-000053.md) | [1.0 d](/filings/0000799233-26-000006.md) | [(14.9)](/filings/0000799233-26-000028.md) | [(12.4)](/filings/0000799233-26-000039.md) | [(7.3)](/filings/0000799233-25-000053.md) | [(22.8) d](/filings/0000799233-26-000006.md) | [(3.3)](/filings/0000799233-26-000028.md) | [16.5](/filings/0000799233-26-000039.md) |
| Interest expense | $m | [6.1](/filings/0000799233-24-000041.md) | not reported | [5.3](/filings/0000799233-25-000036.md) | [4.6](/filings/0000799233-25-000044.md) | [4.2](/filings/0000799233-25-000053.md) | not reported | [3.1](/filings/0000799233-26-000028.md) | [3.0](/filings/0000799233-26-000039.md) | [2.9](/filings/0000799233-25-000053.md) | not reported | [2.2](/filings/0000799233-26-000028.md) | [1.9](/filings/0000799233-26-000039.md) |
| Income tax | $m | [(2.5)](/filings/0000799233-24-000041.md) | [(0.0) d](/filings/0000799233-26-000006.md) | [(4.2)](/filings/0000799233-25-000036.md) | [(0.5)](/filings/0000799233-25-000044.md) | [(1.8)](/filings/0000799233-25-000053.md) | [(0.4) d](/filings/0000799233-26-000006.md) | [(4.0)](/filings/0000799233-26-000028.md) | [(4.3)](/filings/0000799233-26-000039.md) | [(1.6)](/filings/0000799233-25-000053.md) | [(5.7) d](/filings/0000799233-26-000006.md) | [(0.5)](/filings/0000799233-26-000028.md) | [4.5](/filings/0000799233-26-000039.md) |
| Net income | $m | [(10.7)](/filings/0000799233-24-000041.md) | not reported | [(15.1)](/filings/0000799233-25-000053.md) | [(3.5)](/filings/0000799233-25-000053.md) | [(9.3)](/filings/0000799233-25-000053.md) | not reported | [(13.9)](/filings/0000799233-26-000039.md) | [(10.9)](/filings/0000799233-26-000039.md) | [(8.3)](/filings/0000799233-25-000053.md) | not reported | [(4.8)](/filings/0000799233-26-000039.md) | [10.6](/filings/0000799233-26-000039.md) |
| Diluted EPS | $ per share | [(0.14)](/filings/0000799233-24-000041.md) | not reported | [(0.19)](/filings/0000799233-25-000036.md) | [(0.04)](/filings/0000799233-25-000044.md) | [(0.12)](/filings/0000799233-25-000053.md) | not reported | [(0.18)](/filings/0000799233-26-000028.md) | [(0.14)](/filings/0000799233-26-000039.md) | [(0.11)](/filings/0000799233-25-000053.md) | not reported | [(0.06)](/filings/0000799233-26-000028.md) | [0.14](/filings/0000799233-26-000039.md) |
| Basic EPS | $ per share | [(0.14)](/filings/0000799233-24-000041.md) | not reported | [(0.19)](/filings/0000799233-25-000036.md) | [(0.04)](/filings/0000799233-25-000044.md) | [(0.12)](/filings/0000799233-25-000053.md) | not reported | [(0.18)](/filings/0000799233-26-000028.md) | [(0.14)](/filings/0000799233-26-000039.md) | [(0.11)](/filings/0000799233-25-000053.md) | not reported | [(0.06)](/filings/0000799233-26-000028.md) | [0.14](/filings/0000799233-26-000039.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.1](/filings/0000799233-24-000041.md) | [28.1](/filings/0000799233-26-000006.md) | [23.8](/filings/0000799233-25-000036.md) | [23.9](/filings/0000799233-25-000044.md) | [30.7](/filings/0000799233-25-000053.md) | [12.8](/filings/0000799233-26-000006.md) | [23.9](/filings/0000799233-26-000028.md) | [22.9](/filings/0000799233-26-000039.md) | [32.7](/filings/0000799233-25-000053.md) | [18.5](/filings/0000799233-26-000039.md) | [44.5](/filings/0000799233-26-000028.md) | [62.4](/filings/0000799233-26-000039.md) |
| Current assets | $m | [182](/filings/0000799233-23-000049.md) | [169](/filings/0000799233-25-000008.md) | [160](/filings/0000799233-24-000020.md) | [164](/filings/0000799233-24-000030.md) | [157](/filings/0000799233-24-000041.md) | [129](/filings/0000799233-26-000006.md) | [140](/filings/0000799233-25-000036.md) | [136](/filings/0000799233-25-000044.md) | [138](/filings/0000799233-25-000053.md) | [115](/filings/0000799233-26-000039.md) | [143](/filings/0000799233-26-000028.md) | [186](/filings/0000799233-26-000039.md) |
| Total assets | $m | [1,576](/filings/0000799233-23-000049.md) | [1,510](/filings/0000799233-25-000008.md) | [1,452](/filings/0000799233-24-000020.md) | [1,413](/filings/0000799233-24-000030.md) | [1,361](/filings/0000799233-24-000041.md) | [1,334](/filings/0000799233-26-000006.md) | [1,345](/filings/0000799233-25-000036.md) | [1,299](/filings/0000799233-25-000044.md) | [1,258](/filings/0000799233-25-000053.md) | [1,192](/filings/0000799233-26-000039.md) | [1,181](/filings/0000799233-26-000028.md) | [1,175](/filings/0000799233-26-000039.md) |
| Current liabilities | $m | [142](/filings/0000799233-23-000049.md) | [123](/filings/0000799233-25-000008.md) | [127](/filings/0000799233-24-000020.md) | [134](/filings/0000799233-24-000030.md) | [135](/filings/0000799233-24-000041.md) | [120](/filings/0000799233-26-000006.md) | [156](/filings/0000799233-25-000036.md) | [144](/filings/0000799233-25-000044.md) | [121](/filings/0000799233-25-000053.md) | [110](/filings/0000799233-26-000039.md) | [113](/filings/0000799233-26-000028.md) | [117](/filings/0000799233-26-000039.md) |
| Long-term debt | $m | [335](/filings/0000799233-23-000049.md) | [291](/filings/0000799233-25-000008.md) | [255](/filings/0000799233-24-000020.md) | [229](/filings/0000799233-24-000030.md) | [198](/filings/0000799233-24-000041.md) | [192](/filings/0000799233-26-000006.md) | [189](/filings/0000799233-25-000036.md) | [183](/filings/0000799233-25-000044.md) | [178](/filings/0000799233-25-000053.md) | [154](/filings/0000799233-26-000039.md) | [150](/filings/0000799233-26-000028.md) | [135](/filings/0000799233-26-000039.md) |
| Current portion of debt | $m | [9.1](/filings/0000799233-23-000049.md) | [9.3](/filings/0000799233-24-000041.md) | [9.0](/filings/0000799233-24-000020.md) | [8.6](/filings/0000799233-24-000030.md) | [8.7](/filings/0000799233-24-000041.md) | [9.0](/filings/0000799233-25-000053.md) | [10.7](/filings/0000799233-25-000036.md) | [11.1](/filings/0000799233-25-000044.md) | [7.8](/filings/0000799233-25-000053.md) | [5.7](/filings/0000799233-26-000039.md) | [0.0](/filings/0000799233-26-000028.md) | [0.0](/filings/0000799233-26-000039.md) |
| Shareholders' equity | $m | [861](/filings/0000799233-24-000041.md) | [865](/filings/0000799233-26-000006.md) | [849](/filings/0000799233-25-000053.md) | [837](/filings/0000799233-25-000053.md) | [826](/filings/0000799233-25-000053.md) | [823](/filings/0000799233-26-000039.md) | [808](/filings/0000799233-26-000039.md) | [787](/filings/0000799233-26-000039.md) | [776](/filings/0000799233-25-000053.md) | [755](/filings/0000799233-26-000039.md) | [749](/filings/0000799233-26-000039.md) | [756](/filings/0000799233-26-000039.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [27.2 d](/filings/0000799233-24-000041.md) | [40.8 d](/filings/0000799233-26-000006.md) | [31.0](/filings/0000799233-25-000036.md) | [40.0 d](/filings/0000799233-25-000044.md) | [35.6 d](/filings/0000799233-25-000053.md) | [37.8 d](/filings/0000799233-26-000006.md) | [25.8](/filings/0000799233-26-000028.md) | [21.0 d](/filings/0000799233-26-000039.md) | [27.5 d](/filings/0000799233-25-000053.md) | [14.9 d](/filings/0000799233-26-000006.md) | [23.2](/filings/0000799233-26-000028.md) | [12.9 d](/filings/0000799233-26-000039.md) |
| Capital expenditure | $m | [68.8 d](/filings/0000799233-24-000041.md) | [31.7 d](/filings/0000799233-26-000006.md) | [4.7](/filings/0000799233-25-000036.md) | [10.5 d](/filings/0000799233-25-000044.md) | [11.0 d](/filings/0000799233-25-000053.md) | [83.3 d](/filings/0000799233-26-000006.md) | [23.6](/filings/0000799233-26-000028.md) | [33.8 d](/filings/0000799233-26-000039.md) | [39.7 d](/filings/0000799233-25-000053.md) | [59.1 d](/filings/0000799233-26-000006.md) | [18.0](/filings/0000799233-26-000028.md) | [47.4 d](/filings/0000799233-26-000039.md) |
| Dividends paid | $m | [1.6 d](/filings/0000799233-24-000041.md) | [3.2 d](/filings/0000799233-26-000006.md) | [0.0](/filings/0000799233-25-000036.md) | [1.6 d](/filings/0000799233-25-000044.md) | [1.6 d](/filings/0000799233-25-000053.md) | [1.6 d](/filings/0000799233-26-000006.md) | [1.6](/filings/0000799233-26-000028.md) | [1.6 d](/filings/0000799233-26-000039.md) | [1.6 d](/filings/0000799233-25-000053.md) | [1.5 d](/filings/0000799233-26-000006.md) | [1.6](/filings/0000799233-26-000028.md) | [1.6 d](/filings/0000799233-26-000039.md) |
| Share repurchases | $m | [0.0 d](/filings/0000799233-24-000041.md) | [0.0 d](/filings/0000799233-26-000006.md) | not reported | not reported | [0.0 d](/filings/0000799233-25-000053.md) | [0.0 d](/filings/0000799233-26-000006.md) | not reported | not reported | [1.4 d](/filings/0000799233-25-000053.md) | [0.0 d](/filings/0000799233-26-000006.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [79.0](/filings/0000799233-23-000049.md) | [79.0](/filings/0000799233-24-000020.md) | [79.1](/filings/0000799233-24-000030.md) | [79.1](/filings/0000799233-24-000041.md) | [79.1](/filings/0000799233-25-000036.md) | [79.0](/filings/0000799233-25-000044.md) | [78.5](/filings/0000799233-25-000053.md) | [78.6](/filings/0000799233-26-000028.md) | [78.1](/filings/0000799233-26-000039.md) | [77.5](/filings/0000799233-25-000053.md) | [77.5](/filings/0000799233-26-000028.md) | [77.4](/filings/0000799233-26-000039.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 77,332,611 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0000799233-26-000039.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.